AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 40.19 |
Market Cap | 5.82B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 2.05 |
PE Ratio (ttm) | 48.74 |
Forward PE | n/a |
Analyst | Buy |
Ask | 159.82 |
Volume | 561,198 |
Avg. Volume (20D) | 428,550 |
Open | 98.39 |
Previous Close | 95.64 |
Day's Range | 96.99 - 100.05 |
52-Week Range | 70.70 - 108.08 |
Beta | undefined |
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac interventi...
Analyst Forecast
According to 10 analyst ratings, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is $110, which is an increase of 10.09% from the latest price.
Next Earnings Release
Analysts project revenue of $346.76M, reflecting a 6.85% YoY growth and earnings per share of 0.82, making a 1.23% increase YoY.
2 months ago · seekingalpha.com
Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call TranscriptMerit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd...